Position in VNDA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$440,487
-$52,389 QoQ
Shares Held
71,975
+0.9% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. VNDA ranks #195 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in VNDA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $440,487 | 71,975 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $492,876 | 71,328 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $646,020 | 73,245 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $425,612 | 85,293 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $408,497 | 86,546 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $394,276 | 85,899 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $435,597 | 90,939 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $422,625 | 90,112 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $562,480 | 99,554 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $404,111 | 98,324 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $422,025 | 100,006 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $440,385 | 101,941 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,335,845 | 202,708 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,314,598 | 193,608 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,368,058 | 185,123 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,735,342 | 175,642 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,907,805 | 175,028 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,870,866 | 165,417 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,644,800 | 168,566 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,936,236 | 171,309 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 ALXN | — | 421,197 | Shares | Sole | 2021-08-05 | |
| 2021-06-30 | $4,123,983 | 191,724 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 ALXN | — | 429,036 | Shares | Sole | 2021-05-06 | |
| 2021-03-31 | $3,017,082 | 200,871 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 ALXN | — | 449,884 | Shares | Sole | 2021-02-10 | |
| 2020-12-31 | $2,643,505 | 201,180 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 ALXN | — | 487,028 | Shares | Sole | 2020-11-12 | |
| 2020-09-30 | $1,770,745 | 183,307 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 ALXN | — | 493,904 | Shares | Sole | 2020-08-13 | |
| 2020-06-30 | $2,275,187 | 198,880 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 ALXN | — | 459,104 | Shares | Sole | 2020-05-06 | |
| 2020-03-31 | $1,818,490 | 175,530 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||